Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NKTR)

Historical Holders from Q1 2014 to Q3 2025

Symbol
NKTR on Nasdaq
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
20,788,527
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
7,236
Holdings value
$411,673
% of all portfolios
0%
Number of holders
7
Number of buys
3
Number of sells
-2
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NKTR)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 6.7% $9,270,724 12,528,006 BlackRock, Inc. 31 Mar 2025
EVENTIDE ASSET MANAGEMENT, LLC 3.61% $4,921,000 6,650,000 Eventide Asset Management, LLC 31 Dec 2024
Deep Track Capital, LP 1.07% $1,462,239 1,975,998 Deep Track Capital, LP 31 Dec 2024

Institutional Holders of Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NKTR)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 7,236 $411,673 +$299,814 $56.9 7
2025 Q2 6,448 $52,906 -$84,345,665 $25.84 7
2025 Q1 123,832,570 $84,191,414 -$9,619,052 $0.68 156
2024 Q4 132,887,132 $123,564,418 -$10,051,378 $0.93 144
2024 Q3 140,728,695 $182,906,836 +$5,561,656 $1.3 138
2024 Q2 135,417,464 $167,916,168 +$31,189,751 $1.24 132
2024 Q1 112,890,288 $105,437,293 -$4,637,674 $0.9342 117
2023 Q4 119,190,605 $67,330,899 -$14,356,167 $0.565 119
2023 Q3 143,162,977 $85,280,943 +$3,466,954 $0.5956 130
2023 Q2 137,616,980 $79,156,536 -$21,632,445 $0.5752 138
2023 Q1 172,656,651 $121,134,385 -$6,847,947 $0.7029 187
2022 Q4 169,134,728 $382,214,358 -$28,072,203 $2.26 209
2022 Q3 175,467,213 $561,862,456 -$30,006,635 $3.2 208
2022 Q2 182,451,737 $693,387,846 +$14,942,655 $3.8 203
2022 Q1 175,738,382 $947,161,661 -$12,647,310 $5.39 217
2021 Q4 173,960,187 $2,350,617,677 +$60,793,716 $13.51 225
2021 Q3 167,527,305 $3,008,326,722 -$15,294,872 $17.96 228
2021 Q2 167,936,090 $2,881,857,625 -$33,251,989 $17.16 231
2021 Q1 169,693,928 $3,392,531,228 -$52,781,602 $20 224
2020 Q4 172,290,053 $2,929,156,988 -$17,045,988 $17 232
2020 Q3 175,748,755 $2,915,926,690 -$42,045,853 $16.59 238
2020 Q2 174,896,826 $4,050,261,692 -$44,584,638 $23.16 249
2020 Q1 177,174,980 $3,164,197,295 +$12,315,614 $17.85 234
2019 Q4 175,849,330 $3,795,370,239 -$40,913,708 $21.58 270
2019 Q3 178,006,422 $3,241,831,055 +$139,183,084 $18.22 272
2019 Q2 165,918,824 $5,899,886,319 +$833,932,879 $35.58 327
2019 Q1 162,897,398 $5,472,194,669 -$66,824,317 $33.6 340
2018 Q4 164,848,349 $5,418,580,035 +$34,325,427 $32.87 322
2018 Q3 159,600,491 $9,729,032,838 -$26,508,318 $60.96 375
2018 Q2 160,416,782 $7,832,434,531 -$143,968,898 $48.83 368
2018 Q1 157,039,690 $16,679,618,668 +$350,934,157 $106.26 349
2017 Q4 154,603,092 $9,233,952,173 +$80,601,155 $59.72 261
2017 Q3 153,912,042 $3,692,685,792 +$66,532,732 $24 203
2017 Q2 151,352,082 $2,959,589,678 +$123,309,771 $19.55 196
2017 Q1 146,311,934 $3,432,643,057 +$471,797,573 $23.47 198
2016 Q4 145,044,414 $1,779,787,465 +$106,710,874 $12.27 196
2016 Q3 133,535,856 $2,292,233,354 -$7,287,187 $17.18 189
2016 Q2 134,393,493 $1,912,184,366 -$65,595,760 $14.23 171
2016 Q1 139,138,306 $1,913,174,245 -$6,784,614 $13.75 172
2015 Q4 139,481,833 $2,350,145,705 -$21,167,934 $16.85 177
2015 Q3 141,683,540 $1,552,778,761 +$30,862,779 $10.96 165
2015 Q2 138,173,841 $1,728,114,850 +$152,141,225 $12.51 177
2015 Q1 126,069,547 $1,386,834,636 +$59,685,451 $11 152
2014 Q4 120,120,654 $1,861,694,087 +$32,166,353 $15.5 162
2014 Q3 118,403,758 $1,429,229,131 +$50,525,687 $12.07 144
2014 Q2 114,184,350 $1,463,381,133 -$20,592,506 $12.82 141
2014 Q1 115,845,050 $1,403,687,024 +$164,733,234 $12.12 138